152 related articles for article (PubMed ID: 36645163)
21. Prostate cancer grading in 2018: limitations, implementations, cribriform morphology, and biological markers.
Montironi R; Cimadamore A; Cheng L; Lopez-Beltran A; Scarpelli M
Int J Biol Markers; 2018 Nov; 33(4):331-334. PubMed ID: 29945478
[TBL] [Abstract][Full Text] [Related]
22. Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma.
Montironi R; Cimadamore A; Gasparrini S; Mazzucchelli R; Santoni M; Massari F; Cheng L; Lopez-Beltran A; Scarpelli M
Expert Rev Anticancer Ther; 2018 Jul; 18(7):685-693. PubMed ID: 29699428
[TBL] [Abstract][Full Text] [Related]
23. Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study.
Bulten W; Pinckaers H; van Boven H; Vink R; de Bel T; van Ginneken B; van der Laak J; Hulsbergen-van de Kaa C; Litjens G
Lancet Oncol; 2020 Feb; 21(2):233-241. PubMed ID: 31926805
[TBL] [Abstract][Full Text] [Related]
24. Utility of Gleason pattern 4 morphologies detected on transrectal ultrasound (TRUS)-guided biopsies for prediction of upgrading or upstaging in Gleason score 3 + 4 = 7 prostate cancer.
Flood TA; Schieda N; Keefe DT; Breau RH; Morash C; Hogan K; Belanger EC; Mai KT; Robertson SJ
Virchows Arch; 2016 Sep; 469(3):313-9. PubMed ID: 27394432
[TBL] [Abstract][Full Text] [Related]
25. Impact of Cribriform Pattern and Intraductal Carcinoma on Gleason 7 Prostate Cancer Treated with External Beam Radiotherapy.
Tom MC; Nguyen JK; Lucianò R; Mian OY; Stephans KL; Ciezki JP; Smile TD; Wei W; McKenney JK; Magi-Galluzzi C; Tendulkar RD
J Urol; 2019 Oct; 202(4):710-716. PubMed ID: 31059665
[TBL] [Abstract][Full Text] [Related]
26. Dataset for the reporting of prostate carcinoma in core needle biopsy and transurethral resection and enucleation specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR).
Egevad L; Judge M; Delahunt B; Humphrey PA; Kristiansen G; Oxley J; Rasiah K; Takahashi H; Trpkov K; Varma M; Wheeler TM; Zhou M; Srigley JR; Kench JG
Pathology; 2019 Jan; 51(1):11-20. PubMed ID: 30477882
[TBL] [Abstract][Full Text] [Related]
27. Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation.
Srigley JR; Delahunt B; Samaratunga H; Billis A; Cheng L; Clouston D; Evans A; Furusato B; Kench J; Leite K; MacLennan G; Moch H; Pan CC; Rioux-Leclercq N; Ro J; Shanks J; Shen S; Tsuzuki T; Varma M; Wheeler T; Yaxley J; Egevad L
Pathology; 2019 Aug; 51(5):463-473. PubMed ID: 31279442
[TBL] [Abstract][Full Text] [Related]
28. Utility of Pathology Imagebase for standardisation of prostate cancer grading.
Egevad L; Delahunt B; Berney DM; Bostwick DG; Cheville J; Comperat E; Evans AJ; Fine SW; Grignon DJ; Humphrey PA; Hörnblad J; Iczkowski KA; Kench JG; Kristiansen G; Leite KRM; Magi-Galluzzi C; McKenney JK; Oxley J; Pan CC; Samaratunga H; Srigley JR; Takahashi H; True LD; Tsuzuki T; van der Kwast T; Varma M; Zhou M; Clements M
Histopathology; 2018 Jul; 73(1):8-18. PubMed ID: 29359484
[TBL] [Abstract][Full Text] [Related]
29. Interobserver Reproducibility of Percent Gleason Pattern 4 in Prostatic Adenocarcinoma on Prostate Biopsies.
Sadimin ET; Khani F; Diolombi M; Meliti A; Epstein JI
Am J Surg Pathol; 2016 Dec; 40(12):1686-1692. PubMed ID: 27487740
[TBL] [Abstract][Full Text] [Related]
30. The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies.
Billis A; Guimaraes MS; Freitas LL; Meirelles L; Magna LA; Ferreira U
J Urol; 2008 Aug; 180(2):548-52; discussion 552-3. PubMed ID: 18550106
[TBL] [Abstract][Full Text] [Related]
31. Cribriform architecture prostatic adenocarcinoma in needle biopsies is a strong independent predictor for lymph node metastases in radical prostatectomy.
Downes MR; Xu B; van der Kwast TH
Eur J Cancer; 2021 May; 148():432-439. PubMed ID: 33077335
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
Herawi M; Epstein JI
Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
[TBL] [Abstract][Full Text] [Related]
33. Going deeper through the Gleason scoring scale: An automatic end-to-end system for histology prostate grading and cribriform pattern detection.
Silva-Rodríguez J; Colomer A; Sales MA; Molina R; Naranjo V
Comput Methods Programs Biomed; 2020 Oct; 195():105637. PubMed ID: 32653747
[TBL] [Abstract][Full Text] [Related]
34. Gleason score 3 + 4=7 prostate cancer with minimal quantity of gleason pattern 4 on needle biopsy is associated with low-risk tumor in radical prostatectomy specimen.
Huang CC; Kong MX; Zhou M; Rosenkrantz AB; Taneja SS; Melamed J; Deng FM
Am J Surg Pathol; 2014 Aug; 38(8):1096-101. PubMed ID: 24832163
[TBL] [Abstract][Full Text] [Related]
35. Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists.
Iczkowski KA; Egevad L; Ma J; Harding-Jackson N; Algaba F; Billis A; Camparo P; Cheng L; Clouston D; Comperat EM; Datta MW; Evans AG; Griffiths DF; Guo CC; Hailemariam S; Huang W; Humphrey PA; Jiang Z; Kahane H; Kristiansen G; La Rosa FG; Lopez-Beltran A; MacLennan GT; Magi-Galluzzi C; Merrimen J; Montironi R; Osunkoya AO; Picken MM; Rao N; Shah RB; Shanks JH; Shen SS; Tawfik OW; True LD; Van der Kwast T; Varma M; Wheeler TM; Zynger DL; Sahr N; Bostwick DG
Ann Diagn Pathol; 2014 Dec; 18(6):333-42. PubMed ID: 25263387
[TBL] [Abstract][Full Text] [Related]
36. Gleason grading: past, present and future.
Delahunt B; Miller RJ; Srigley JR; Evans AJ; Samaratunga H
Histopathology; 2012 Jan; 60(1):75-86. PubMed ID: 22212079
[TBL] [Abstract][Full Text] [Related]
37. Concordance of cribriform architecture in matched prostate cancer biopsy and radical prostatectomy specimens.
Hollemans E; Verhoef EI; Bangma CH; Schoots I; Rietbergen J; Helleman J; Roobol MJ; van Leenders GJLH
Histopathology; 2019 Sep; 75(3):338-345. PubMed ID: 31045262
[TBL] [Abstract][Full Text] [Related]
38. An update of the Gleason grading system.
Epstein JI
J Urol; 2010 Feb; 183(2):433-40. PubMed ID: 20006878
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of percentage Gleason grade 5 prostatic adenocarcinoma in needle biopsies from patients treated by radical prostatectomy.
Yaxley W; Delahunt B; Yaxley J; Thunders MC; Kenwright DN; Egevad L; Samaratunga H
Pathology; 2022 Oct; 54(6):694-699. PubMed ID: 35613972
[TBL] [Abstract][Full Text] [Related]
40. Standardization of Gleason grading among 337 European pathologists.
Egevad L; Ahmad AS; Algaba F; Berney DM; Boccon-Gibod L; Compérat E; Evans AJ; Griffiths D; Grobholz R; Kristiansen G; Langner C; Lopez-Beltran A; Montironi R; Moss S; Oliveira P; Vainer B; Varma M; Camparo P
Histopathology; 2013 Jan; 62(2):247-56. PubMed ID: 23240715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
